Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients With Chronic Low Back Pain - Drugs.com MedNews
Links shared publicly online about this topic.
- 843total visits
Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients With Chronic Low Back Pain - Drugs.com MedNews
View full resource at drugs.com
Tags: Pain Medication, Pain, Back Pain, Drug, Phase 3 Clinical Trial, Safety
Most Recently Shared on September 27, 2010 at 2:10 pm By:
Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients With Chronic Low Back Pain:... http://bit.ly/cqnARq #drug
Phase 3 Study Compares Tapentadol Extended Release Tablets To Placebo In Patients With Chronic Low Back Pain - QualityPoint Technologies
qualitypointtech.net — “Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic low back pain have been published online by Expert Opinion on Pharmacotherapy. In addition, this study compared oxycodone controlled-release (CR) to placebo as an active control. Tapentadol ER vs. Placebo The study demonstrated that a significantly higher percentage of patients receiving tapentadol ER tablets achieved at l” View full resource at qualitypointtech.net
Most Recently Shared on September 28, 2010 at 12:00 pm By:
Phase 3 Study Compares Tapentadol Extended Release Tablets To Placebo In Patients With Chronic Low Back Pain: Phas... http://bit.ly/cPcs1D
Advertisement
